Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if REVB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
12 filers reported a long position in REVB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | $216.9K | 210.6K | +111.8% |
| CITADEL ADVISORS LLC | $39.7K | 38.6K | New |
| GEODE CAPITAL MANAGEMENT, LLC | $17.7K | 17.2K | -60.2% |
| HRT FINANCIAL LP | $17K | 17K | New |
| VANGUARD FIDUCIARY TRUST CO | $13.5K | 13.1K | Unchanged |
| Tower Research Capital LLC (TRC) | $6.7K | 6.5K | +60.2% |
| ROYAL BANK OF CANADA | $1K | 747 | Unchanged |
| SBI Securities Co., Ltd. | $354 | 344 | Unchanged |
| BARCLAYS PLC | $173 | 168 | New |
| HARBOUR INVESTMENTS, INC. | $42 | 41 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.